This inventor holds 47 USPTO granted patents and 19 published patent applications, plus 1 CIPO patent and 25 EPO patents, primarily in Pharmaceutical Composition. Top assignees: Chia Tai Tianqing Pharmaceutical Group Co., Ltd., Centaurus Biopharma Co., Ltd., Lianyungang Runzhong Pharmaceutical Co., Ltd.. Active years: 2013-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Lianyunganag, CN (2020)
- Lianyungang, CN (2018 - 2023)
- Jiangsu, CN (2013 - 2024)
Company Filing History:
40 out of 121 
10 out of 33 
10 out of 26 Years Active: 2013-2026
Areas of Expertise:
Title: Innovations and Contributions of Xiquan Zhang in Pharmaceutical Patents
Introduction: Xiquan Zhang, an accomplished inventor based in Lianyungang, China, has made significant strides in the field of pharmaceuticals. With an impressive portfolio of 35 patents, Zhang's work focuses on innovative treatments for various cancers, notably colorectal cancer. His commitment to advancing medical science through innovative solutions highlights his role as a leading figure in the pharmaceutical industry.
Latest Patents: Xiquan Zhang's recent patents showcase his expertise and dedication to medical advancements. One notable patent is for a TLR7 agonist utilized in treating colorectal cancer. The disclosed compound, along with its pharmaceutically acceptable salts, significantly contributes to therapeutic strategies against this prevalent form of cancer. Additionally, the patent outlines a pharmaceutical combination featuring the TLR7 agonist and a tyrosine kinase inhibitor, presenting a novel approach to enhance treatment efficacy. Another pivotal patent involves a pharmaceutical composition of a humanized monoclonal anti-PD-L1 antibody, which consists of specific concentrations of the antibody, alongside buffers and stabilizers. This formulation aims to prevent antibody aggregation while maintaining biological binding activity over time, thus improving treatment outcomes for patients.
Career Highlights: Throughout his career, Xiquan Zhang has worked with notable companies such as Chia Tai Tianqing Pharmaceutical Group Co., Ltd. and Centaurus Biopharma Co., Ltd. His contributions in these organizations emphasize his commitment to developing innovative pharmaceutical solutions that can significantly improve cancer treatment paradigms.
Collaborations: Zhang has collaborated with esteemed colleagues, including Aiming Zhang and Xin Tian. Their collective expertise and efforts push the boundaries of research, leading to groundbreaking advancements in pharmaceutical sciences.
Conclusion: Xiquan Zhang's innovative patents and career accomplishments reflect a genuine drive to enhance cancer treatments through advanced pharmaceutical formulations. His recent inventions not only demonstrate his expertise in biotechnology but also underscore the importance of collaboration in scientific research. As the medical community continues to seek effective solutions to complex health issues, Zhang's contributions will undoubtedly play a pivotal role in shaping future therapeutic options.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile